PLUS THERAPEUTICS, INC. — Director's Dealing 2009

Dec 21, 2009

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CYTORI THERAPEUTICS, INC. (CYTX)
CIK: 0001095981
Period of Report: 2009-12-18

Reporting Person: RICKEY DAVID (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2009-12-18	Common Stock	X	7676	$2.62	Acquired	20911	Indirect

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2009-05-07	Warrant to Purchase Common Stock	$2.62	X	7676	Acquired	2014-05-12	Common Stock (7676)	Indirect

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	124800	Indirect
Common Stock	34909	Indirect
Common Stock	4106	Direct

Footnotes

F1: On December 18, 2009 the Dave Rickey & Daughters Foundation exercised a Warrant for the purchase of 7,676 shares of the Company's Common stock pursuant to a Securities Purchase Agreement dated May 9, 2009. The Agreement provided for a purchase 4,386 Units ("Unit") at a purchase price of $2.28 per Unit. Each Unit consisted of 1 unregistered share of the Company's Common Stock and a Warrant ("Warrant") to purchase 1.75 shares of Common Stock. The exercise price of the Warrant was $2.62 per share. The Warrant was immediately exercisable upon issuance, and was to expire on the fifth anniversary of its issue date.

F2: These securities are owned by the Dave Rickey and Daughters Foundation.

F3: These securities are owned by David Rickey, TTEE FBO the David Rickey Trust.

F4: These securities are owned by the Rickey Family Limited Partnership.